Shares of ArisInfra Solutions, a tech-driven B2B platform in the construction materials space, are trading at a grey market premium (GMP) of approximately ₹25 (11.26%) above the upper price band, despite cooling slightly from ₹30 (13.5%) last Friday. With the IPO set to open on June 18, investor enthusiasm is evident—but the recent dip signals growing caution.
IPO Highlights: Key Details
- Issue Size: ₹499.6 crore through a fresh issue of 2.25 crore shares
- Price Band: ₹210–₹222 per share
- GMP Today: ₹25 (11.26%) above upper band – implying a potential listing price of ₹247
- Anchor Book Opens: June 17
- IPO Opens: June 18; Closes: June 20
- Allotment Date: By June 23; Tentative Listing: June 25 on BSE & NSE
Investor Categories & Lot Sizes
| Investor Type | Allocation | Lot Size | Investment at Upper Band |
|---|---|---|---|
| Retail | 10% | 67 shares | ₹14,874 |
| Non-Institutional (NII) | 15% | 14 lots | ₹2,08,236 |
| Qualified Institutional (QIB) | 75% | – | Significant institutional inflows expected |
Company Overview & Business Model
Established in 2021 and backed by PharmEasy co-founder Siddharth Shah, ArisInfra Solutions is revolutionizing B2B procurement of construction materials like steel, cement, and aggregates. Its platform streamlines ordering, logistics, quality control, and on-time delivery with seamless digital integration.
Since inception, ArisInfra has:
- Supplied over 10 million tonnes (April 2021 – March 2024), now at 14.1 million tonnes to Dec 2024
- Engaged 1,729 vendors and supplied to 2,659 customers across 1,075 pin codes
- Served marquee clients like Capacit’e, Afcons, J Kumar, and others
Use of Proceeds
IPO sale proceeds are earmarked for:
- Repayment of borrowings
- Bolstering working capital
- Investing in subsidiary Buildmex-Infra
- General corporate purposes
- Potential inorganic acquisitions
GMP Trend & Investor Sentiment
- GMP on Friday (June 13): ₹30 (13.5%)
- GMP on closing (June 17): ₹25 (11.26%)
- Lowering premium suggests early investors are booking gains; listing-time investors may bargain.
But an expected ~11% listing pop indicates solid demand—especially among retail investors.
Bullish Case
- High Growth Potential: Addresses inefficient, fragmented $220 bn construction materials market
- Tech-Backed Model: Digital interface + supply chain coordination adds competitive advantage
- Strong Scale: Rapid TTM volume growth and vendor/caller network increase lead on-time delivery
- Institutional Support: Promotions from PharmEasy co-founder and renowned lead managers like JM, IIFL, Nuvama
Risks to Watch
- GMP Fluctuations: Extended price pops may drop before listing
- Reliance on Vendors: Scaling dependences may strain control and margins
- Competition: New and existing infra-tech startups may intensify pressure
- Execution Risk: Scaling tech, logistics, and working capital is operationally complex
Investor Checklist
- Retail candidates: Subscribe at cut‑off (₹222) for better allotment chances
- Anchor investors: Early institutional traction is crucial—track anchor book fills
- Post-listing: Monitor GMP and trade volumes; listing likely June 25
- Long-term view: Evaluate growth trajectory, cash flow discipline, expansion pace
Conclusion
ArisInfra Solutions’ IPO is generating solid buzz, with a grey market premium near 11% hinting at high initial demand. The upcoming launch is promising, but dip in GMP suggests cautious profit-taking. Investors should balance listing gains with sustained growth potential and execution capability in a competitive sector.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Please consult a qualified advisor before making investment decisions.
Also Read: Biocon Shares Edge Up as Board Sets ₹340.20 Floor Price for ₹4,500 Cr QIP
